Alpine Immune Sciences (ALPN) Revenue & Revenue Breakdown
Alpine Immune Sciences Revenue Highlights
Latest Revenue (Y)
$58.88M
Latest Revenue (Q)
$7.03M
Main Segment (Y)
Product
Main Geography (Y)
Product
Alpine Immune Sciences Revenue by Period
Alpine Immune Sciences Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $58.88M | 95.84% |
| 2022-12-31 | $30.06M | 28.24% |
| 2021-12-31 | $23.44M | 151.13% |
| 2020-12-31 | $9.34M | 436.49% |
| 2019-12-31 | $1.74M | 146.81% |
| 2018-12-31 | $705.00K | -59.27% |
| 2017-12-31 | $1.73M | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2012-12-31 | - | - |
Alpine Immune Sciences generated $58.88M in revenue during NA 2023, up 95.84% compared to the previous quarter, and up 8351.21% compared to the same period a year ago.
Alpine Immune Sciences Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $7.03M | -77.21% |
| 2023-12-31 | $30.85M | 207.21% |
| 2023-09-30 | $10.04M | 16.87% |
| 2023-06-30 | $8.59M | -8.46% |
| 2023-03-31 | $9.39M | 238.15% |
| 2022-12-31 | $2.78M | -66.82% |
| 2022-09-30 | $8.37M | 58.11% |
| 2022-06-30 | $5.29M | -61.17% |
| 2022-03-31 | $13.63M | 200.86% |
| 2021-12-31 | $4.53M | -46.81% |
| 2021-09-30 | $8.52M | 18.39% |
| 2021-06-30 | $7.19M | 124.50% |
| 2021-03-31 | $3.20M | -43.22% |
| 2020-12-31 | $5.64M | 194.98% |
| 2020-09-30 | $1.91M | 178.05% |
| 2020-06-30 | $688.00K | -36.94% |
| 2020-03-31 | $1.09M | 23.42% |
| 2019-12-31 | $884.00K | 205.88% |
| 2019-09-30 | $289.00K | -49.03% |
| 2019-06-30 | $567.00K | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | -100.00% |
| 2018-06-30 | $390.00K | 23.81% |
| 2018-03-31 | $315.00K | 146.09% |
| 2017-12-31 | $128.00K | - |
| 2017-09-30 | $128.00K | -82.66% |
| 2017-06-30 | $738.00K | 0.14% |
| 2017-03-31 | $737.00K | -0.14% |
| 2016-12-31 | $738.00K | 0.14% |
| 2016-09-30 | $737.00K | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2015-03-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2014-09-30 | - | 100.00% |
| 2014-06-30 | - | 100.00% |
| 2014-03-31 | - | - |
Alpine Immune Sciences generated $7.03M in revenue during Q1 2024, up -77.21% compared to the previous quarter, and up 253.31% compared to the same period a year ago.
Alpine Immune Sciences Revenue Breakdown
Alpine Immune Sciences Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 21 | Dec 20 |
|---|---|---|---|
| Product | $762.00M | $23.40M | $7.00M |
Alpine Immune Sciences's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product (100.00%).
Quarterly Revenue by Product
| Product/Service | Mar 24 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Sep 19 | Jun 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Product | $337.50M | $4.50M | $8.50M | $7.20M | $3.20M | $5.40M | $356.00K | $602.00K | $1.10M | $288.00K | $142.00K |
Alpine Immune Sciences's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Product (100.00%).
Alpine Immune Sciences Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 21 | Dec 20 |
|---|---|---|
| Product | $23.40M | $7.00M |
Alpine Immune Sciences's latest annual revenue breakdown by geography, as of Dec 21: Product (100.00%).
Quarterly Revenue by Country
| Country | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Sep 19 | Jun 19 |
|---|---|---|---|---|---|---|---|---|---|---|
| Product | $4.50M | $8.50M | $7.20M | $3.20M | $5.40M | $356.00K | $602.00K | $1.10M | $288.00K | $142.00K |
Alpine Immune Sciences's latest quarterly revenue breakdown by geography, as of Dec 21: Product (100.00%).
Alpine Immune Sciences Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| AMLX | Amylyx Pharmaceuticals | $380.79M | $416.00K |
| BCYC | Bicycle Therapeutics | $26.98M | $2.68M |
| ADAG | Adagene | $18.11M | $833.34K |
| ANAB | AnaptysBio | $17.16M | $30.02M |
| STOK | Stoke Therapeutics | $8.78M | $4.89M |
| IGMS | IGM Biosciences | $2.13M | $516.00K |
| ANEB | Anebulo Pharmaceuticals | - | - |
| DAWN | Day One Biopharmaceuticals | - | $20.07M |
| ABOS | Acumen Pharmaceuticals | - | - |
| TERN | Terns Pharmaceuticals | - | - |
| ACRV | Acrivon Therapeutics | - | - |
| MLYS | Mineralys Therapeutics | - | - |
| GLUE | Monte Rosa Therapeutics | - | $4.70M |
| MLTX | MoonLake Immunotherapeutics | - | - |
| TNYA | Tenaya Therapeutics | - | - |